Further, other studies have shown that down regulation of tumour suppressive miR-126 [27] and miR-128 [26] results in the promotion of tumour-associated lymphangiogenesis, which was assessed by the subsequent reduction of a lymphangiogenic marker LYVE1. The gene discussed is LYVE1; the disease is neoplasm.